Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception

Bethany D. Panchal, Rebecca Cash, Camille Moreno, Emily Vrontos, Cheryl Bourne, Sandra Palmer, Amy Simpson and Ashish R. Panchal
The Journal of the American Board of Family Medicine July 2019, 32 (4) 474-480; DOI: https://doi.org/10.3122/jabfm.2019.04.180281
Bethany D. Panchal
From Department of Family Medicine, The Ohio State University College of Medicine, Columbus, OH (BDP, EV, CB, SP, AS); Division of Epidemiology, The Ohio State University College of Public Health (RC, ARP); Department of OB/GYN and Specialized Women's Health, Cleveland Clinic Foundation, Cleveland, OH (CM); Department of Emergency Medicine, The Ohio State University College of Medicine (ARP).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Cash
From Department of Family Medicine, The Ohio State University College of Medicine, Columbus, OH (BDP, EV, CB, SP, AS); Division of Epidemiology, The Ohio State University College of Public Health (RC, ARP); Department of OB/GYN and Specialized Women's Health, Cleveland Clinic Foundation, Cleveland, OH (CM); Department of Emergency Medicine, The Ohio State University College of Medicine (ARP).
MPH, NRP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camille Moreno
From Department of Family Medicine, The Ohio State University College of Medicine, Columbus, OH (BDP, EV, CB, SP, AS); Division of Epidemiology, The Ohio State University College of Public Health (RC, ARP); Department of OB/GYN and Specialized Women's Health, Cleveland Clinic Foundation, Cleveland, OH (CM); Department of Emergency Medicine, The Ohio State University College of Medicine (ARP).
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily Vrontos
From Department of Family Medicine, The Ohio State University College of Medicine, Columbus, OH (BDP, EV, CB, SP, AS); Division of Epidemiology, The Ohio State University College of Public Health (RC, ARP); Department of OB/GYN and Specialized Women's Health, Cleveland Clinic Foundation, Cleveland, OH (CM); Department of Emergency Medicine, The Ohio State University College of Medicine (ARP).
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl Bourne
From Department of Family Medicine, The Ohio State University College of Medicine, Columbus, OH (BDP, EV, CB, SP, AS); Division of Epidemiology, The Ohio State University College of Public Health (RC, ARP); Department of OB/GYN and Specialized Women's Health, Cleveland Clinic Foundation, Cleveland, OH (CM); Department of Emergency Medicine, The Ohio State University College of Medicine (ARP).
CNP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Palmer
From Department of Family Medicine, The Ohio State University College of Medicine, Columbus, OH (BDP, EV, CB, SP, AS); Division of Epidemiology, The Ohio State University College of Public Health (RC, ARP); Department of OB/GYN and Specialized Women's Health, Cleveland Clinic Foundation, Cleveland, OH (CM); Department of Emergency Medicine, The Ohio State University College of Medicine (ARP).
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Simpson
From Department of Family Medicine, The Ohio State University College of Medicine, Columbus, OH (BDP, EV, CB, SP, AS); Division of Epidemiology, The Ohio State University College of Public Health (RC, ARP); Department of OB/GYN and Specialized Women's Health, Cleveland Clinic Foundation, Cleveland, OH (CM); Department of Emergency Medicine, The Ohio State University College of Medicine (ARP).
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashish R. Panchal
From Department of Family Medicine, The Ohio State University College of Medicine, Columbus, OH (BDP, EV, CB, SP, AS); Division of Epidemiology, The Ohio State University College of Public Health (RC, ARP); Department of OB/GYN and Specialized Women's Health, Cleveland Clinic Foundation, Cleveland, OH (CM); Department of Emergency Medicine, The Ohio State University College of Medicine (ARP).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Mitchell AA,
    2. Gilboa SM,
    3. Werler MM,
    4. et al
    . Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. Am J Obstet Gynecol 2011;205:51.e1–8.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Egen-Lappe V,
    2. Hasford J
    . Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 2004;60:659–66.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Daw JR,
    2. Hanley GE,
    3. Greyson DL,
    4. Morgan SG
    . Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf 2011;20:895–902.
    OpenUrlPubMed
  4. 4.↵
    1. Andrade SE,
    2. Gurwitz JH,
    3. Davis RL,
    4. et al
    . Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191:398–407.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Lee E,
    2. Maneno MK,
    3. Smith L,
    4. et al
    . National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf 2006;15:537–45.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Schwarz EB,
    2. Maselli J,
    3. Norton M,
    4. Gonzales R
    . Prescription of teratogenic medications in United States ambulatory practices. Am J Med 2005;118:1240–9.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Schwarz EB,
    2. Postlethwaite DA,
    3. Hung YY,
    4. Armstrong MA
    . Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women. Ann Intern Med 2007;147:370–6.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Fritsche MD,
    2. Ables AZ,
    3. Bendyk H
    . Opportunities missed: improving the rate of contraceptive counseling or provision when prescribing reproductive-aged women potentially teratogenic medications in a family medicine resident clinic. Contraception 2011;84:372–6.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Schwarz EB,
    2. Santucci A,
    3. Borrero S,
    4. Akers AY,
    5. Nikolajski C,
    6. Gold MA
    . Perspectives of primary care clinicians on teratogenic risk counseling. Birth Defects Res A Clin Mol Teratol 2009;85:858–63.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Pace LE,
    2. Schwarz EB
    . Balancing act: safe and evidence-based prescribing for women of reproductive age. Womens Health (Lond) 2012;8:415–25.
    OpenUrl
  11. 11.↵
    1. Garcia-Bournissen F,
    2. Tsur L,
    3. Goldstein LH,
    4. et al
    . Fetal exposure to isotretinoin-an international problem. Reprod Toxicol 2008;25:124–8.
    OpenUrlCrossRefPubMed
  12. 12.↵
    iPledge: committed to pregnancy prevention. 2016. Available from: https://www.ipledgeprogram.com/iPledgeUI/home.u. Accessed September 16, 2018.
  13. 13.↵
    Isotretinoin (marketed as Accutane) capsule information. United States Department of Health and Human Services, 2007. Available from: https://www.fda.gov/Drugs/DrugSafety/ucm094305.htm. Accessed September 16, 2018.
  14. 14.↵
    1. Danielsson B,
    2. Wikner BN,
    3. Kallen B
    . Use of ondansetron during pregnancy and congenital malformations in the infant. Reprod Toxicol 2014;50:134–7.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Carstairs SD
    . Ondansetron use in pregnancy and birth defects: a systematic review. Obstet Gynecol 2016;127:878–83.
    OpenUrlPubMed
  16. 16.↵
    POISONDEX (Micromedex 2.0). 2018. Available from: https://www.micromedexsolutions.com/micromedex2/librarian/. Accessed March 12, 2018.
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 32 (4)
The Journal of the American Board of Family Medicine
Vol. 32, Issue 4
July-August 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception
Bethany D. Panchal, Rebecca Cash, Camille Moreno, Emily Vrontos, Cheryl Bourne, Sandra Palmer, Amy Simpson, Ashish R. Panchal
The Journal of the American Board of Family Medicine Jul 2019, 32 (4) 474-480; DOI: 10.3122/jabfm.2019.04.180281

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception
Bethany D. Panchal, Rebecca Cash, Camille Moreno, Emily Vrontos, Cheryl Bourne, Sandra Palmer, Amy Simpson, Ashish R. Panchal
The Journal of the American Board of Family Medicine Jul 2019, 32 (4) 474-480; DOI: 10.3122/jabfm.2019.04.180281
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Implementing Practice Changes in Family Medicine to Enhance Care and Prevent Disease Progression
  • Google Scholar

More in this TOC Section

  • Associations Between Modifiable Preconception Care Indicators and Pregnancy Outcomes
  • Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion
  • Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool
Show more Original Research

Similar Articles

Keywords

  • Child Health
  • Community Medicine
  • Contraception
  • Counseling
  • Infant Health
  • Lisinopril
  • Logistic Models
  • Ondansetron
  • Pharmacoepidemiology
  • Primary Health Care
  • Preconception Care
  • Pregnancy
  • Prenatal Care
  • Reproductive Health
  • Teratogens

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire